| Gene symbol | CTAG1B | Synonyms | CTAG, ESO1, CT6.1, CTAG1, LAGE-2, LAGE2B, NY-ESO-1 | Type of gene | protein-coding | |
| Chromosome | X | Map location | Xq28 | dbXrefs | Entrez:1485 MIM:300156 HGNC:HGNC:2491 Ensembl:ENSG00000184033 AllianceGenome:HGNC:2491 | |
| Description | cancer/testis antigen 1B | |||||
| GTO ID | GTC0313 |
| Trial ID | NCT02774291 |
| Disease | Metastatic Cancer |
| Altered gene | NY-ESO-1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | NY-ESO-1 TCR-T cells |
| Co-treatment | Filgrastim |
| HLA | HLA-A*02:01 |
| Phase | Phase1 |
| Recruitment status | Terminated |
| Title | Pilot Study of Adoptive Cell Transfer for the Treatment of Metastatic Cancer That Expresses NY-ESO-1 Using Lymphodepleting Conditioning Followed by Infusion of Anti-NY ESO-1 Murine TCR-Gene Engineered Lymphocytes |
| Year | 2016 |
| Country | United States |
| Company sponsor | Albert Einstein College of Medicine |
| Other ID(s) | 2015-5254|NCI-2015-01781|2015-5254|P30CA013330 |
| Cohort 1 | |||||||||||||
|
|||||||||||||